ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On May 4, 2023, Nuvation Bio Inc. issued a press release announcing its financial results for the quarter ended March 31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

The information contained in this Form 8-K, including in the accompanying Exhibit 99.1, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS




(d)  Exhibits.

Exhibit
Number    Description

99.1        Press Release of Nuvation Bio Inc. dated May 4, 2023.

104       Cover Page Interactive Data File (embedded within XBRL document)



                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses